Tumor target volume for focal therapy of prostate cancer-does multiparametric magnetic resonance imaging allow for a reliable estimation?

[1]  P. Scardino,et al.  Focal therapy in prostate cancer: international multidisciplinary consensus on trial design. , 2014, European urology.

[2]  K. Rha,et al.  Prevalence and management of lower urinary tract symptoms in methamphetamine abusers: an under-recognized clinical identity. , 2014, The Journal of urology.

[3]  Karin Haustermans,et al.  Multiparametric MRI for prostate cancer localization in correlation to whole‐mount histopathology , 2013, Journal of magnetic resonance imaging : JMRI.

[4]  P. P. Iu,et al.  ESUR prostate MR guidelines. , 2013, European radiology.

[5]  Naira Muradyan,et al.  Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. , 2013, The Journal of urology.

[6]  A. Fenster,et al.  Registration of prostate histology images to ex vivo MR images via strand‐shaped fiducials , 2012, Journal of magnetic resonance imaging : JMRI.

[7]  Baris Turkbey,et al.  Correlation of magnetic resonance imaging tumor volume with histopathology. , 2012, The Journal of urology.

[8]  Aaron Fenster,et al.  Prostate: registration of digital histopathologic images to in vivo MR images acquired by using endorectal receive coil. , 2012, Radiology.

[9]  Rémy Prost,et al.  Robust Alignment of Prostate Histology Slices With Quantified Accuracy , 2012, IEEE Transactions on Biomedical Engineering.

[10]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[11]  H. Ahmed.  Focal therapy will become standard treatment for localized prostate cancer: pro. , 2012, The Journal of urology.

[12]  Baris Turkbey,et al.  Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.

[13]  Thomas Hambrock,et al.  Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.

[14]  B. Carey,et al.  Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.

[15]  H. Hricak,et al.  Semi‐automatic deformable registration of prostate MR images to pathological slices , 2010, Journal of Magnetic Resonance Imaging.

[16]  Piotr Kozlowski,et al.  Device for sectioning prostatectomy specimens to facilitate comparison between histology and in vivo MRI , 2010, Journal of magnetic resonance imaging : JMRI.

[17]  Thomas Hambrock,et al.  Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. , 2010, The Journal of urology.

[18]  A. Prando.  Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume , 2009 .

[19]  Jason A Koutcher,et al.  Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. , 2009, Radiology.

[20]  Laurent Lemaitre,et al.  Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance , 2009, Current opinion in urology.

[21]  Clare Allen,et al.  Dynamic contrast enhanced MRI in prostate cancer. , 2007, European journal of radiology.

[22]  A. Villers,et al.  Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. , 2006, The Journal of urology.

[23]  Magnus Hellström,et al.  Tissue shrinkage after fixation with formalin injection of prostatectomy specimens , 2006, Virchows Archiv.

[24]  L. Egevad,et al.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.

[25]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[26]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[27]  A. Schned,et al.  Tissue-shrinkage correction factor in the calculation of prostate cancer volume. , 1996, The American journal of surgical pathology.

[28]  A. Partin,et al.  Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: pathogenetic and clinical implications. , 1994, The Journal of urology.

[29]  D. Grignon,et al.  Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens. , 1989, Urology.

[30]  T. Stamey,et al.  Morphometric and clinical studies on 68 consecutive radical prostatectomies. , 1988, The Journal of urology.

[31]  Baris Turkbey,et al.  Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. , 2012, Urology.

[32]  Thomas Hambrock,et al.  Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. , 2012, European urology.

[33]  P. Walsh,et al.  Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. , 2002, The Journal of urology.

[34]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.